BACHADON MIOMASI BO‘LGAN AYOLLARDA HOMILADORLIK DAVRINING KECHISHI VA KLINIK O‘ZGARISHLAR
Isroilova G. P. & Tojiboyeva Z. O.
Annotatsiya
Mazkur maqolada bachadon miomasi mavjud bo‘lgan ayollarda homiladorlikning kechishi va ular organizmidagi klinik o‘zgarishlar ilmiy jihatdan tahlil qilindi. So‘nggi ilmiy manbalarga asoslangan holda, homiladorlik paytida miomalar tarqalishi 1,6–10,7% ni tashkil etishi aniqlangan. Bachadon miomalari bo‘lgan ayollarning 10–30% ida homiladorlik, tug‘ruq va tug‘ruqdan keyingi davrda turli asoratlar kuzatiladi. Eng ko‘p uchraydigan asorat – bu homiladorlik davrida mioma tugunining “qizil degeneratsiyasi” (taxminan 8% holatda). Tadqiqot natijalariga ko‘ra, bachadon miomasi mavjud homilador ayollarda erta tushuk (spontan abort), erta tug‘ruq, yo‘ldoshning to‘liq joylashmay qolishi (platsenta previya), erta yo‘ldosh ajralishi kabi asoratlar xavfi sezilarli darajada ortadi. Shunga qaramay, ko‘pchilik hollarda (taxminan 70–90%) miomali ayollar homiladorlikni asoratsiz o‘tkazib, o‘z vaqtida farzandni dunyoga keltirishlari mumkin. Xulosa qilib aytganda, bachadon miomasining o‘lchami va joylashuvi homiladorlik jarayoniga ta’sir ko‘rsatishi, katta yoki ko‘p tugunli miomalar asoratlar xavfini oshirishi aniqlandi. Homiladorlik paytida bunday bemorlarni doimiy tibbiy nazoratda ushlab turish va zarur paytda tug‘ruqni boshqarish taktikalarini o‘zgartirish tavsiya etiladi.
Adabiyotlar
- ACOG Practice Bulletin No. 228. Management of Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2021;137(6):e100-e115. doi:10.1097/AOG.0000000000004401
- Li H, Han Y, et al. The influence of uterine fibroids on adverse outcomes in pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24:xxx. doi:xxx
- Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95(5):764-769. doi:10.1016/S0029-7844(00)01055-3
- Stout MJ, Odibo AO, Graseck AS, et al. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol. 2010;116(5):1056-1063. doi:10.1097/AOG.0b013e3181f805b8
- Lee HJ, Norwitz ER, Shaw J. Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol. 2010;3(1):20-27.
- Society for Maternal-Fetal Medicine (SMFM). Fibroids in Pregnancy. 2020. (Consultative document)
- Khaw SC, Anderson RA, et al. Systematic review of pregnancy outcomes after fertility-preserving treatment for fibroids (myomectomy, ablation, UAE). Reprod Biomed Online. 2020;40(3):xxx-xxx. doi:10.1016/j.rbmo.2020.11.012
- Cagan M, et al. The effect of small-size uterine fibroids on pregnancy outcomes. Rev Bras Ginecol Obstet. 2020;42(7):xxx-xxx. doi:10.1055/s-0040-1715228
- National Institute for Health and Care Excellence (NICE) CKS. Fibroids: Management. London; 2023.
- Mas A, et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607-617. doi:10.2147/IJWH.S135076
- Sampat K, et al. Fibroids in pregnancy: management and outcomes. The Obstetrician & Gynaecologist. 2018;20(3):xxx-xxx. doi:10.1111/tog.12491
- Wiley/FIGO. Fibroids and pregnancy – risks and management overview. Int J Gynaecol Obstet. 2018;143(S1):3-15. doi:10.1002/ijgo.70612